BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9444881)

  • 1. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy.
    Brugada R; Kelsey W; Lechin M; Zhao G; Yu QT; Zoghbi W; Quinones M; Elstein E; Omran A; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R; Marian AJ
    J Investig Med; 1997 Dec; 45(9):542-51. PubMed ID: 9444881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
    Perkins MJ; Van Driest SL; Ellsworth EG; Will ML; Gersh BJ; Ommen SR; Ackerman MJ
    Eur Heart J; 2005 Nov; 26(22):2457-62. PubMed ID: 16087648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of angiotensinogen gene M235T variant with hypertrophic cardiomyopathy].
    Cai SY; Shi YP; Yu F; Xu G
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):280-2. PubMed ID: 15192838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
    Abchee A; Marian AJ
    J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy.
    Wang SX; Fu CY; Zou YB; Wang H; Shi Y; Xu XQ; Chen JZ; Song XD; Huan TJ; Hui RT
    Chin Med J (Engl); 2008 Jan; 121(1):27-31. PubMed ID: 18208662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.
    Patel R; Lim DS; Reddy D; Nagueh SF; Lutucuta S; Sole MJ; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    J Mol Cell Cardiol; 2000 Dec; 32(12):2369-77. PubMed ID: 11113012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Lechin M; Quiñones MA; Omran A; Hill R; Yu QT; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R
    Circulation; 1995 Oct; 92(7):1808-12. PubMed ID: 7671365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-genetic aspects of the hypotensive response and regression of left ventricular hypertrophy in arterial hypertension patients].
    Moiseev VS; Kotovskaia IuV; Kobalava ZhD; Nosikov VV; Korovina EP; Timofeeva SG
    Ter Arkh; 2002; 74(10):30-7. PubMed ID: 12469628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.
    Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A
    Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in angiotensin II type 2 receptor gene influences extent of left ventricular hypertrophy in hypertrophic cardiomyopathy independent of blood pressure.
    Carstens N; van der Merwe L; Revera M; Heradien M; Goosen A; Brink PA; Moolman-Smook JC
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):274-80. PubMed ID: 21163866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.
    Osterop AP; Kofflard MJ; Sandkuijl LA; ten Cate FJ; Krams R; Schalekamp MA; Danser AH
    Hypertension; 1998 Nov; 32(5):825-30. PubMed ID: 9822439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism of vascular angiotensin II receptor gene and cardiovascular disorders].
    Chistiakov DA; Kobalova ZhD; Tereshchenko SN; Moiseev SV; Nosikov VV
    Ter Arkh; 2000; 72(4):27-30. PubMed ID: 10833794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of polymorphisms of the angiotensin-converting enzyme and angiotensinogen genes on the phenotypic expression of Spanish patients with hypertrophic cardiomyopathy].
    López-Haldón J; García-Lozano JR; Martínez Martínez A; Núñez-Roldán A; Burgos Cornejo J
    Med Clin (Barc); 1999 Jul; 113(5):161-3. PubMed ID: 10480137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of the angiotensinogen M235T and the angiotensin-converting enzyme I/D polymorphisms on arterial hypertension and other cardiovascular risk factors].
    Pamies Andreu E; Palmero Palmero C; García Lozano R; Stiefel García-Junco P; Miranda Guisado ML; Martín Sanz V; Villar Ortiz J; Núñez Roldán A; Carneado de la Fuente J
    Med Clin (Barc); 1999 Jul; 113(5):164-8. PubMed ID: 10480138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can angiotensin II +1675 G/A type 2 receptor gene polymorphism be a marker of left ventricular hypertrophy in patients with aortic stenosis?
    Orlowska-Baranowska E; Placha G; Baranowski R; Michalek P; Gora J; Gaciong Z; Stepinska J
    J Heart Valve Dis; 2007 Sep; 16(5):495-503. PubMed ID: 17944121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of left ventricular hypertrophy expression in patients with hypertrophic cardiomyopathy on the basis of sex.
    Dimitrow PP; Czarnecka D; Jaszcz KK; Dubiel JS
    J Cardiovasc Risk; 1998 Apr; 5(2):85-7. PubMed ID: 9821060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.